Showing results (51-60 of 336) with videos related to
Sort By:
Pageof 34
Therapeutic Advances in Hematology|June 12, 2020
The role of romiplostim for pediatric patients with immune thrombocytopeniaHanny Al-Samkari, Rachael F Grace, David J KuterJournal of Thrombosis and Thrombolysis|June 20, 2023
Antithrombotic therapy for atrial fibrillation in hereditary hemorrhagic telangiectasiaZain M Virk, T Lee Richardson, Hanny Al-SamkariJournal of Immunotherapy (Hagerstown, Md. : 1997)|July 6, 2022
Pembrolizumab-Induced Acquired Amegakaryocytic Thrombocytopenia and Successful Combination Treatment With Eltrombopag, Romiplostim and Cyclosporine: A Brief CommunicationAlbert K Park, Jong C Park, Hanny Al-SamkariBritish Journal of Haematology|February 6, 2024
The problem of immune thrombocytopenia refractory to both eltrombopag and romiplostimHanny Al-Samkari, Alexandra Schifferli, Tomas J Gonzalez-LopezJournal of Thrombosis and Haemostasis : JTH|July 10, 2026
Direct Glycoprotein-Specific Platelet Autoantibodies Detected in a Majority of Patients with Persistent Chemotherapy-Induced ThrombocytopeniaAndrew B Song, Brian R Curtis, Hanny Al-SamkariExpert Opinion on Pharmacotherapy|October 23, 2020
An evaluation of avatrombopag for the treatment of thrombocytopeniaZain Mohammad Virk, David J Kuter, Hanny Al-SamkariExpert Review of Hematology|July 29, 2024
Novel treatments for immune thrombocytopenia: targeting platelet autoantibodiesShreyash Dalmia, Brian Harnett, Hanny Al-Samkari, et al.Annals of Hematology|November 18, 2018
Platelet aggregation response in immune thrombocytopenia patients treated with romiplostimHanny Al-Samkari, Elizabeth M Van Cott, David J KuterTrends in Molecular Medicine|March 19, 2023
Updates and advances in pyruvate kinase deficiencyNeeti Luke, Kirsty Hillier, Hanny Al-Samkari, et al.Pageof 34